Cost-effectiveness of PCSK9 Inhibitors: Proof in the Modeling. Editorial Article uri icon

Overview

publication date

  • December 1, 2017

Research

keywords

  • Anticholesteremic Agents
  • Proprotein Convertase 9

Identity

Scopus Document Identifier

  • 85040001292

Digital Object Identifier (DOI)

  • 10.1001/jamacardio.2017.3656

PubMed ID

  • 29049827

Additional Document Info

volume

  • 2

issue

  • 12